Our Illinois medical malpractice lawyers have been discussing the potential risk of metal-on-metal devices for several months. The DePuy hip recall and subsequent filing of Illinois hip implant lawsuits have led many observers, including those involved in regulating these products, to take a second look at their safety.
This week the New York Times reported on a new move by the Food and Drug Administration to further ensure the health and safety of those receiving hip implants. The Agency has ordered all metal-on-metal hip implant manufacturers to conduct research on the patients who have the device in order to determine if they are linked to early failure rates or health problems.
One of the main side effects that will be examined is the rate at which metal particles may be shed into the patient’s bloodstream causing soft tissue damage.
The FDA order is a rare step for clinical trial after a product has reached the market. However, the fact that these hip implant devices were brought to consumers through a fast-tracked approval process which meant that many of these implants had little, if any clinical testing beforehand.
Readers will remember that the national concern about these devices began last August when DePuy Orthopedics issued a recall of its nearly 100,000 metal-on-metal implants after thousands of cases of early failure rates and dangerous health effects were identified.
Our Chicago hip implant lawyers at Levin & Perconti are encouraged by steps taken to ensure increased safety for hip implant patients. Our work with the victims of this and similar medical errors makes clear that a safe approval process is needed to guarantee that new equipment does not pose unsafe risks of harm. Patients typically rely on the advice of their doctor when it comes to these options. Therefore they have a reasonable expectation that their doctor will not suggest products that are unsafe.
See Our Related Blog Posts: